Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Frailty model with change points for survival analysis39
Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real‐World Setting25
Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data22
Pre‐Posterior Distributions in Drug Development and Their Properties19
A Likelihood Perspective on Dose‐Finding Study Designs in Oncology18
Average Hazard as Harmonic Mean18
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long‐term endpoint: The non‐Gaussian case17
Improved inference forMCP‐Modapproach using time‐to‐event endpoints with small sample sizes16
Estimators for handling COVID‐19‐related intercurrent events with a hypothetical strategy14
14
A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials14
Improving early phase oncology clinical trial design: The case for finding the optimal biological dose13
CUSUMIN: A cumulative sum interval design for cancer phase I dose finding studies13
Issue Information13
0.69371891021729